Soraya Azari, MD
Dr. Azari completed her undergraduate and medical school training on the East coast and returned to California for residency at UCSF in the San Francisco General Primary Care (SFPC) program. She completed a Chief Residency year at San Francisco General Hospital and is currently a Clinician Educator based at Zuckerberg San Francisco General. She has worked in resident education, serving as an Associate Program Director, and then Interim Program Director for the SFPC Track and recently transitioned to serving as the Associate Program Director for the Primary Care Addiction Fellowship program at San Francisco General Hospital. She is board certified in Internal Medicine and Addiction Medicine.
No relevant financial relationships to disclose.

Christopher Blazes, MD
Dr. Blazes is Assistant Professor of Psychiatry and Emergency Medicine at OHSU. He is triple board-certified in psychiatry, addiction psychiatry, and emergency medicine and is the director of the OHSU addiction psychiatry Fellowship. Dr Blazes is a clinician educator whose practice is based out of the Portland VA Medical Center. He lectures widely and publishes on such topics as benzodiazepines, synthetic fentanyl analogues, buprenorphine, and the neurobiology of addiction and recovery.
No relevant financial relationships to disclose.

David Kan, MD
Dr. Kan graduated from Northwestern University Medical School. He finished his General Psychiatry Residency and Forensic Psychiatry Fellowship at the University of California, San Francisco (UCSF). He is Board-certified by the American Board of Psychiatry and Neurology in General and Forensic Psychiatry and he is Board-Certified by the American Board of Addiction Medicine in Addiction Medicine. He is a member of the faculty at the UCSF Department of Psychiatry.
No relevant financial relationships to disclose.

Jack McCarthy, MD
Dr. McCarthy was Executive/Medical of Bi-Valley Medical Clinic Opioid Treatment Program from 1980-2015. He has been on the teaching faculty in the Department of Psychiatry at University of California, Davis since 1980. His research interests are in methadone treatment and pregnancy. Since retirement from clinical practice in 2015, he has co-authored a number of publications on methadone metabolism and on opioid dependence in pregnancy. He is a member of the CSAM Committee on Opioids and of the ASAM Women’s Action Group.
No relevant financial relationships to disclose.

Tauheed Zaman, MD
Dr. Zaman is a Medical Director at the San Francisco VA Medical Center, CA. He has developed workshops on behavioral addictions, performance-enhancing drugs and models of integrated psychiatric/primary care for APA and Institute on Psychiatric Services (IPS) annual meetings. He has also advocated in Washington, DC, for funding of residency training and mental health services for veterans. 
No relevant financial relationships to disclose.